QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=78E40C0FFADCBF682E4195FF9A885D26;jsessionid=29A450B155478D22D1A63086B38D4E02;jsessionid=3C52097363BAB6B6A35DBDB206170327;jsessionid=CC7E3D6DBF1464A4363CD78DA2C1FAAA;jsessionid=905511C437A543075C7C2B254CB7D2C4 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=78E40C0FFADCBF682E4195FF9A885D26;jsessionid=29A450B155478D22D1A63086B38D4E02;jsessionid=3C52097363BAB6B6A35DBDB206170327;jsessionid=CC7E3D6DBF1464A4363CD78DA2C1FAAA;jsessionid=905511C437A543075C7C2B254CB7D2C4